MDMA

A Food and Drug Administration (FDA) advisory panel overwhelmingly rejected MDMA-assisted therapy for treating post-traumatic stress disorder (PTSD). in early August, citing significant concerns about the treatment and research process. Among the primary issues were design flaws in clinical trials...

Drug Science and University College London (UCL) announced a strategic partnership to advance research into MDMA-assisted psychotherapy. This collaboration aims to refine our understanding of how MDMA works in conjunction with psychotherapeutic treatments, addressing concerns that the "...

Less than a month after the FDA rejected MDMA for PTSD treatment, and days after the agency set a September meeting to discuss psychedelic and other treatments for PTSD, the Multidisciplinary Association for Psychedelic Studies (MAPS) awarded a $200,000 grant to Emory University researchers for a...

As summer fades, many of us reflect on its swift passage. For me, the season was a mix of joy and ongoing tasks after a lengthy construction project at our beach house. Similarly, the cannabis and psychedelics industries are grappling with their own extended “construction” phases. They...

A groundbreaking study published in Scientific Reports offers the most comprehensive analysis yet of how classic psychedelics, such as LSD and psilocybin, and the drug MDMA (commonly known as ecstasy) impact cognitive functions during and after use. As PsyPost reported, the research reveals that...

The recent rejection by the Food and Drug Administration (FDA) of an application that would have authorized the use of MDMA for the treatment of post-traumatic stress disorder (PTSD) reignited the already ongoing discussion on psychedelic-assisted therapies. This not only affects the 13 million...

The Food and Drug Administration (FDA) this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD, disappointing many Americans who suffer with intractable mental health conditions and had pinned their hopes on the treatment....

The U.S. Food and Drug Administration (FDA) is on the verge of making a historic decision regarding the approval of Lykos Therapeutics MDMA-assisted therapy as a mainstream medical treatment for post-traumatic stress disorder (PTSD). The decision, expected by August 11, could mark a turning point...

Congressional leaders and veterans’ advocates converged at the U.S. Capitol to push for MDMA-assisted therapy as a potential breakthrough in PTSD treatment for military veterans. The event, marked by the solemn hanging of 150,000 military dog tags symbolizing lives lost to suicide since 9/11...

In an engaging episode of Benzinga’s Cannabis Insider podcast, hosts Patricio Liddle and Nicolás Rodríguez welcomed Cody Shandraw, president of Healing Realty Trust, to discuss the role of real estate in the burgeoning sector of psychedelic therapies. Shandraw, who spearheads the strategic...

New Jersey Lawmakers Amend Psilocybin Measure To Remove Broad Legalization New Jersey Assembly members green-lighted an amendment to a psilocybin bill to align its provisions with a Senate companion version from Senate President Nick Scutari (D) that was recently approved by the Senate Health,...

"Unfortunately, the Committee completely lost sight of the big picture," said retired Lieutenant General of the US Marine Corps, Martin R. Steele. He was commenting on this week's recommendation by a committee of advisors to the U.S. Food and Drug Administration against the approval of MDMA-...

The Magic Mushrooms and MDMA market is hitting new milestones. Canada has licensed Optimi Health Corp. (OTC:OPTHF) to export psilocybin and MDMA to Australia, marking a significant step in the medical psychedelic drugs market. This license allows the Vancouver-based startup to ship controlled...

A panel of advisors to the Food and Drug Administration (FDA) rejected MDMA as a treatment for post-traumatic stress disorder (PTSD) on Tuesday, citing a lack of evidence that the benefits would outweigh the risks of introducing the psychedelic treatment to patients. Most stocks in the psychedelic...

California: Senate Pass Bill Removing Cannabis Employment Protections For Certain Law Enforcement Positions  The state Senate passed a bill scaling down current employment protections for people who consume cannabis legally while off work. The measure that was approved...